Presentation is loading. Please wait.

Presentation is loading. Please wait.

IP Strategies to Improve Innovation and Reduce Risk Patricia Folkins Product Development and Management Association January 28, 2009.

Similar presentations


Presentation on theme: "IP Strategies to Improve Innovation and Reduce Risk Patricia Folkins Product Development and Management Association January 28, 2009."— Presentation transcript:

1 IP Strategies to Improve Innovation and Reduce Risk Patricia Folkins Product Development and Management Association January 28, 2009

2 The Dilemma  IP departments must become more efficient and reduce costs, but not at the expense of the competitive advantage their business derives from its IP portfolio

3

4 Disaster or opportunity?  Inject efficiency into IP management  Are opportunities opening up in the market place due to market changes?

5 Intellectual Property  Currency for controlling access to innovation  Innovation relates to the commercialization of new ideas  Invention is the generation of a new idea to solve a specific problem  Not all inventions result in innovation

6 Components of IP  Inventions, patentable and not patentable  Know-how  Trade Marks  Copyright

7 IP Management and Business Strategy  IP management cannot exist in isolation, must be part of overall business strategy  Driving force is economic - objective is to maximize value creation through IP, not merely to grow an IP portfolio  Value of creations depends on their value in improving competitive position

8 Essentials for Success  Strategic vision  Organizational development  “People Power”

9 Objectives  Mine existing knowledge to facilitate product innovation, product development and cost control  Protect inventions appropriately-neither too much nor too little

10 Three Stage Process  Assessment of IP Assets - “IP Audit”  Create IP Management Plan  Implement Plan

11 Stage 1: Assessment  IP Audit: identify all current IP assets (including existing patents, patent applications, Know-How, Trade Marks, Copyrights)

12 Determination of Business Goals  Understand business goals to ensure that the IP Audit will be useful to overall business strategy  Value of IP is dependent on its successful integration with business strategy

13 Identification of IP Assets  Catalog all IP wherever located  Determine status of IP  Determine relative value of IP to company’s strategic interests  Create catalog, and keep it up to date

14 Patent/Know How Catalog  Will help to recognize existing assets  Identify strengths and weaknesses  Compare IP position with that of competitors  Determine value of patents/know how to company

15 Valuation of IP  Quality, not quantity is important  Assess the relationship between each IP component and business strategy  Does the IP protect present and future business opportunities?  Does the IP help create new opportunities?  Are key markets covered?

16 Stage 2: Create Plan  “Top Down” approach: determine goals, determine what is necessary to achieve goals  “Bottom Up” approach: assess existing assets, see if such assets can be mined to create new opportunities  The two approaches are not necessarily mutually exclusive

17 Create Management Team  Team is responsible for development and management of the IP Plan  Team should include technical, legal, business and marketing personnel under supervision of a senior executive  Management Team could evolve into patent committee at later stage of process

18 Align IP Plan with Overall Strategy  Determine which IP is key, and should be kept exclusive to company  Determine whether any of the company’s IP is licensable to third parties without giving access of company’s technology to competitors  Determine which IP is no longer important and can be abandoned

19 Competitor Analysis  Establish procedure for keeping informed of activities of both competitors and research organizations wherever located  Useful knowledge is not necessarily restricted to company’s core business: might exist in non-competitive fields  Patent searching can be done in-house, and information made available throughout the company

20 Stage 3: Implementation  Motivating internal development of IP  Education  Incentives

21 Patent Committee  Could be same personnel as IP Management Committee  Should meet regularly, e.g. quarterly  Prioritize inventions for patenting, discard applications/patents that no longer are of strategic importance  Be aware of competitors’ IP positions to avoid conflicts

22 IP Management  Consider an IP Coordinator to interface between in-house inventors/scientists/engineers and outside counsel,  Create in-house filing systems for managing and tracking IP assets irrespective where they are created  Establish a central, accurate database of all IP assets and keep the database up to date.

23 IP Management Tasks  Motivate internal IP development  Pool existing Know-How  Determine strategies for managing the protection of new IP irrespective where it originates  Consider extension of existing IP to other markets  Prune existing IP that has little or no commercial importance

24 Challenges  Ensure that IP Assets help company to remain a leader in the development, manufacture and distribution of its products  Ensure a proper balance between protection of IP world-wide and cost  Ensure that the company does not become liable for infringement of third party IP rights

25 Strategic Considerations - Market Dynamics  How will your market change in the face of this unprecedented financial crisis?  Will product lines change or be pared down?  Can you invent into that new market space and patent it?  Can you create new product synergies and patent the combinations and connections?

26 Strategic Considerations - Product/Service Portfolio  Has the economic downturn caused any of your product lines or key customers to become vulnerable to competitors?  Can you combine product packages and services to counter vulnerability? Can these combinations be patented?

27 Strategic Considerations - Business relationships  Keep an eye on suppliers, licensees, business collaborators - are they in distress?  Opportunity to buy but also risk to your business

28 Reducing Costs  First reaction is to scale back on IP protection, e.g. patent filings  Must continue to make long-term decisions for creating a strong IP portfolio that is ready for the “upturn”

29 Use P.O. Delays  Many patent offices have processing delays for initiating examination  Use U.S. Provisionals  Use PCT

30 Watch Claim Scope  Broad claims are likely to be most difficult to obtain and expensive to prosecute  Pursue narrower claims targeted to company’s business (those that cover specific products or that are licensable)  Broader claims may be pursued later in some countries

31 …and numbers  Excess claim fees in many countries  EP: claims in excess of 15 cost 200 Euro each (effective April 9, 2009, claims in excess of 50 will cost 500 Euro each)  US: claims in excess of 20 cost US$52 each, each multiply dependent claim costs US$390 and each independent claim over 3 costs US$220 each

32 Small Entity Status  In US  Individual, small business concern or non-profit  50% reduction in certain fees  Must be under no obligation to assign, grant, convey, or license any part of invention to large entity

33 Better Invention Disclosure Reports  Clearly written comprehensive  Include materials, drawings, descriptions, models  How is the invention distinguishable over the prior art?  What areas do not fall within scope? Include failed experiments  Specify critical parts that make invention operable  Provide in electronic format

34 Communication with outside counsel  Consider SOP  Talk with them about how to reduce costs  What to report?  Keep them up to date on go/no go decisions

35 Case Study

36 Unomedical*  Taken from EPO Website: http://www.epo.org/topics/innovation-and- economy/sme-case- studies/unomedical.html

37 Unomedical  Located in Denmark  Develops and sells single-use medical devices  4000 employees  Sales in 2004: 241 million Euro

38 Unomedical  In 2002 added an IP department  Hired a Group IP Manager  Linked IP department with research and development procedures  “IP plays in everyday decision making”

39 Unomedical  IP issues considered at an “early stage” - before prototype of new product is ready  IP department checks for conflicting patents  If conflicting patents exist may still file to block others

40 Unomedical  Danish Patent Office runs novelty and/or Freedom to Operate searches  Danish Patent Office searches competitor filings 4 times a year  Patent drafting outsourced

41 Unomedical  20 new patent applications filed per year compared to “just a couple” prior to restructuring of IP department  Threatened to sue potential infringer - infringing company pulled product and paid settlement fee

42 12 Key Recommendations from EPO Survey of SME’s  Develop an IP Strategy  Get Professional Help  Choose the right patent attorney/agent  Do not underestimate the cost  Demand information  Adapt your filing strategy to your real business needs

43 12 Key Recommendations from EPO Survey of SME’s  Do not view licensing as failure  Revise your patent portfolio continuously  Start a technology and competitor watch process  Communicate pro-actively  Keep in touch with your licensees  Be sure of your case (for lawsuits)

44

45 www.bereskinparr.com


Download ppt "IP Strategies to Improve Innovation and Reduce Risk Patricia Folkins Product Development and Management Association January 28, 2009."

Similar presentations


Ads by Google